SuperworthOnKure Therapeutics shares outstanding OKUR
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 49.9M
- On a year earlier
- +269.2%
- more shares
OnKure Therapeutics had 49.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 269.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 13.6M | +306% |
| FY2023 | 3.4M | +36% |
| FY2022 | 2.5M | +1% |
| FY2021 | 2.4M | +1092% |
| FY2020 | 205K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 49.9M | +269% | |
| Q1 FY26 | 13.7M | +2% | |
| Q4 FY25 | 13.6M | n/a | |
| Q3 FY25 | 13.5M | +4180% | |
| Q2 FY25 | 13.5M | +4182% | |
| Q1 FY25 | 13.4M | +4175% | |
| Q3 FY24 | 316.1K | −91% | |
| Q2 FY24 | 315.5K | −90% | |
| Q1 FY24 | 314K | −87% | |
| Q4 FY23 | 3.4M | +36% | |
| Q3 FY23 | 3.4M | +38% | |
| Q2 FY23 | 3M | +24% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on OnKure Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.